SciELO - Scientific Electronic Library Online

 
vol.65 número3AToxina botulínica proporciona melhora funcional em pacientes com espasticidade secundária a acidente vascular cerebral?Massagem sobre o nervo occipital maior reduz a intensidade dos ataques de migrânea: evidência de mecanismos de convergência inibitórios trigemino-cervical índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Arquivos de Neuro-Psiquiatria

versão impressa ISSN 0004-282Xversão On-line ISSN 1678-4227

Resumo

MENEZES, Carla; RODRIGUES, Bernardo; MAGALHAES, Elza  e  MELO, Ailton. Botulinum toxin type A in refractory chronic migraine: an open-label trial. Arq. Neuro-Psiquiatr. [online]. 2007, vol.65, n.3a, pp.596-598. ISSN 0004-282X.  http://dx.doi.org/10.1590/S0004-282X2007000400009.

Botulinum toxin type A (BT-A) has been described as an important strategy to various types of pain such as cervical dystonia, myofascial pain syndrome and headache. Although BT-A efficacy has not been proven in tension type headache, its use in migraine continues controversial. In this open trial, we evaluated the efficacy of BT-A in refractory migraine. BT-A was injected in patients diagnosed with migraine who had previously used three classes of prophylactic drugs by at least one year with no response. The most important improvement was observed within 30 days, but pain intensity and frequency of headache had been decreased until the end of three months of follow up. Side effects of BT-A were mild and self limited. We conclude that BT-A seems to be a safe and effective treatment to refractory migraine patients.

Palavras-chave : botulinum toxin type A; migraine; pain; refractory pain.

        · resumo em Português     · texto em Inglês     · Inglês ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons